Display Title ENDO April 2018 Weight 0 Tags ENDO April 2018 Content The Bioavailability of TX-001HR (Estradiol and Micronized Progesterone Capsules): Effect of Food and Varying Dosing Profiles 151.1 KB Baseline Levels of Estradiol (E2) and Estrone (E1) Differ by Age, Race, and BMI in the REPLENISH Trial 319.5 KB Incidence of Abnormal Mammograms with Oral, Combined 17β-Estradiol and Progesterone Capsules 246.3 KB REPLENISH Trial: Relationship Between Changes in Frequency and Severity of Vasomotor Symptoms and Changes in Quality of Life and Sleep Outcomes in Menopausal Women Treated with TX-001HR (Estrogen/Progesterone Oral Combination) 109 KB Novel Oral, Continuous-combined Solubilized 17β-Estradiol and Natural Micronized and Suspended Progesterone Provided Endometrial Protection: Comparison of 2 Randomized Controlled Trials 183 KB Categories Publications
